NeoGenomics to Present at Major Healthcare Event
NeoGenomics, Inc. (NASDAQ: NEO), a prominent company in oncology testing services, is gearing up to participate in the prestigious J.P. Morgan Healthcare Conference. This annual event is known for bringing together leaders in the healthcare sector to discuss innovative advancements and strategic direction.
Event Details
At the conference, Chris Smith, the Chief Executive Officer of NeoGenomics, will take the stage to deliver an insightful presentation. Scheduled for Wednesday, January 15, this presentation will commence at 1:30 p.m. PT, which translates to 4:30 p.m. ET. Following his address, there will be a Q&A session, allowing for interaction and deeper engagement with attendees.
Access to the Presentation
The presentation will be available to a wide audience through a live webcast, ensuring that those unable to attend in person can still benefit from the insights shared. Interested parties will find access details posted on the NeoGenomics website.
About NeoGenomics, Inc.
Specializing in cancer genetics testing, NeoGenomics continues to evolve its capabilities to provide comprehensive services tailored for oncology professionals. The company's offerings include an extensive array of focused tests to assist physicians in diagnosing and treating cancer effectively.
Services Provided
NeoGenomics' Advanced Diagnostic Division plays a vital role by supporting pharmaceutical partners through clinical trials and drug development processes. Their advanced laboratories ensure that clients receive accurate and timely results, crucial for successful patient outcomes.
Laboratory Operations and Locations
Headquartered in Fort Myers, Florida, NeoGenomics boasts several laboratories across the United States, all of which are CAP accredited and CLIA certified. This dedication to quality assurance signifies that the tests conducted meet stringent regulatory standards.
Locations and Reach
The organization operates full-service sample processing labs not only in Fort Myers but also in Aliso Viejo and San Diego, California, as well as in Research Triangle Park, North Carolina, and Houston, Texas. In addition, NeoGenomics has established a laboratory in Cambridge, United Kingdom, bolstering its international presence.
Client Base and Impact
NeoGenomics serves a diverse client base, including pathologists, oncologists, and various healthcare institutions. They collaborate closely with academic centers, hospital systems, pharmaceutical companies, and managed care organizations, enhancing cancer care across the globe.
Commitment to Excellence
The company's commitment to providing high-quality services in cancer diagnostics is unwavering. Through their innovative labs and dedicated staff, NeoGenomics is positioned as a leader in facilitating breakthroughs in cancer treatment.
Frequently Asked Questions
What is the J.P. Morgan Healthcare Conference?
The J.P. Morgan Healthcare Conference is an annual event that showcases advancements in healthcare, featuring presentations from key industry leaders.
Who will be representing NeoGenomics at the event?
Chris Smith, the CEO of NeoGenomics, will present on behalf of the company, discussing their innovations and future direction.
When is NeoGenomics’ presentation scheduled?
NeoGenomics' presentation is set for Wednesday, January 15, at 1:30 p.m. PT/4:30 p.m. ET.
How can I access the presentation?
The presentation will be broadcast live, and access details will be available on NeoGenomics’ website.
What services does NeoGenomics offer?
NeoGenomics provides comprehensive oncology testing services, including genetic testing and support for pharmaceutical clients in clinical trials.
